DiaMedica Therapeutics (DMAC) Sales of Property, Plant and Equipment (2019 - 2021)
Powered by 
Analysis
DiaMedica Therapeutics (DMAC) Sales of Property, Plant and Equipment (2019 - 2021) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Sales of Property, Plant and Equipment (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 209.70 Bn | 195.71 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 180.26 Bn | 177.08 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 132.36 Bn | 124.51 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.46 Bn | 74.47 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 61.27 Bn | 56.09 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.85 Bn | 48.71 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.74 Bn | 30.43 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.62 Bn | 30.33 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.54 Bn | 29.54 Bn | 1.16 Mn | - |
| 10 | DiaMedica Therapeutics | 346.81 Mn | 346.81 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2021 | 2,000.00 |
| Dec 31, 2020 | 16,000.00 |
| Dec 31, 2019 | 1,000.00 |